Vimal Mehta, CEO, President & Secretary at BioXcel Therapeutics, Inc. (BTAI), bought 2,983 shares at $8.67 ($26K) on 2019-08-15, disclosed to the SEC on 2019-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.44 | 358 | $3K | 11.7% |
| 2 | $8.67 | 2,625 | $23K | 88.3% |
| Total | $8.64 avg | 2,983 | $26K | 100% |
| Filing → |
| BTAI | SELL | 2024-09-17 | $1K | — | Filing → |
| BTAI | SELL | 2024-06-18 | $3K | — | Filing → |
| BTAI | SELL | 2024-04-08 | $14K | — | Filing → |